Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Melanoma

  Free Subscription


1 Am J Dermatopathol
1 Biochem Biophys Res Commun
1 Br J Dermatol
1 Int J Cancer
2 Lancet Oncol
1 Melanoma Res
3 Oncol Rep
1 Ophthalmology
2 PLoS Genet

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. BONNELYKKE-BEHRNDTZ ML, Steiniche T, Norgaard P, Danielsen AV, et al
    Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration.
    Am J Dermatopathol. 2017 Mar 18. doi: 10.1097/DAD.0000000000000750.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  2. MUHSIN-SHARAFALDINE MR, Saunderson SC, Dunn AC, McLellan AD, et al
    Melanoma growth and lymph node metastasis is independent of host CD169 expression.
    Biochem Biophys Res Commun. 2017 Mar 27. pii: S0006-291X(17)30613.
    PubMed     Text format     Abstract available

    Br J Dermatol

  3. KOGUCHI-YOSHIOKA H, Okiyama N, Iwamoto K, Matsumura Y, et al
    Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15499.
    PubMed     Text format     Abstract available

    Int J Cancer

  4. TANG JQ, Hou XY, Yang CS, Li YX, et al
    Recent developments in nanomedicine for melanoma treatment.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30708.
    PubMed     Text format     Abstract available

    Lancet Oncol

  5. MENZIES AM, Long GV
    Optimum dosing of ipilimumab in melanoma: too little, too late?
    Lancet Oncol. 2017 Mar 27. pii: S1470-2045(17)30228.
    PubMed     Text format    

  6. ASCIERTO PA, Del Vecchio M, Robert C, Mackiewicz A, et al
    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.
    Lancet Oncol. 2017 Mar 27. pii: S1470-2045(17)30231.
    PubMed     Text format     Abstract available

    Melanoma Res

  7. DE GIORGI V, Grazzini M, Benemei S, Marchionni N, et al
    beta-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.
    Melanoma Res. 2017 Mar 24. doi: 10.1097/CMR.0000000000000317.
    PubMed     Text format     Abstract available

    Oncol Rep

  8. BAI M, Zhang M, Long F, Yu N, et al
    Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Oncol Rep. 2017 Mar 30. doi: 10.3892/or.2017.5537.
    PubMed     Text format     Abstract available

  9. PERDUCA M, Dalle Carbonare L, Bovi M, Innamorati G, et al
    Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL beta-trefoil.
    Oncol Rep. 2017 Mar 6. doi: 10.3892/or.2017.5493.
    PubMed     Text format     Abstract available

  10. SIPOS E, Hegyi K, Treszl A, Steiber Z, et al
    Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5496.
    PubMed     Text format     Abstract available


  11. MOKHTARZADEH A, Harrison AR, Maltry AC
    Malignant Orbital Melanoma Associated with Oculodermal Melanocytosis.
    Ophthalmology. 2017;124:561.
    PubMed     Text format    

    PLoS Genet

  12. UNDERHILL HR, Kitzman JO, Hellwig S, Welker NC, et al
    Fragment Length of Circulating Tumor DNA.
    PLoS Genet. 2016;12:e1006162.
    PubMed     Text format     Abstract available

  13. ZHAO B, Pritchard JR
    Inherited Disease Genetics Improves the Identification of Cancer-Associated Genes.
    PLoS Genet. 2016;12:e1006081.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.